Table 3.
Meta-analysis of the 15 studies* stratified by their geographic origin
| Detection method | No. of studies | Events | Sample size | Point estimates of event rates (fixed effects model) | Point estimates of event rates (random effects model) | Homogeneity (Cochran's Q)** | I-squared (I2)** | Homogeneity(p-value)** | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
| Point estimate | 95% CI | Point estimate | 95% CI | |||||||
| Other Asia | 3 | 4 | 6 | 0.631 | 0.229–0.908 | 0.631 | 0.173–0.933 | 2.878 | 30.510 | 0.237 |
| Europe | 5 | 20 | 56 | 0.356 | 0.226–0.513 | 0.411 | 0.127–0.770 | 10.989 | 63.601 | 0.027 |
| North America | 7 | 14 | 27 | 0.486 | 0.297–0.678 | 0.517 | 0.297–0.730 | 6.808 | 11.867 | 0.339 |
| Summary | 15 | 38 | 89 | 0.422 | 0.311–0.542 | 0.507 | 0.328–0.685 | 22.690 | 38.300 | 0.065 |
| Total within (FE) | 20.675 | 0.055 | ||||||||
| Total between (FE) | 2.015 | 0.365 | ||||||||
| Total between (RE) | 0.467 | 0.792 | ||||||||
All studies reporting only bronchial carcinomas are omitted
Only calculated for fixed effects modelFE – fixed effects, RE – random effects
FE – fixed effects, RE – random effects